Walgreens Boots Alliance Inc. WBA, +1.32% said Thursday it is launching a clinical trial business to help address the problems of access and diversity in the industry. The move comes after recent steps by the U.S. Food and Drug Administration to increase the racial and ethnic diversity of participants in clinical trials, as about 20% of drugs have a variation in response across ethnic groups, even though trials tend to skew predominantly white.